Adaptive Biotechnologies Corp. (ADPT)
25.54
-0.45
(-1.73%)
USD |
NASDAQ |
Aug 24, 16:00
25.54
0.00 (0.00%)
After-Hours: 20:00
Adaptive Biotechnologies Price to Book Value : 28.43 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 28.93 |
| August 20, 2026 | 28.31 |
| August 19, 2026 | 28.37 |
| August 18, 2026 | 27.33 |
| August 17, 2026 | 27.57 |
| August 14, 2026 | 27.54 |
| August 13, 2026 | 27.22 |
| August 12, 2026 | 28.10 |
| August 11, 2026 | 28.26 |
| August 10, 2026 | 28.33 |
| August 07, 2026 | 27.75 |
| August 06, 2026 | 26.27 |
| August 05, 2026 | 27.38 |
| August 04, 2026 | 27.32 |
| August 03, 2026 | 25.72 |
| July 31, 2026 | 25.12 |
| July 30, 2026 | 26.91 |
| July 29, 2026 | 25.11 |
| July 28, 2026 | 25.06 |
| July 27, 2026 | 25.09 |
| July 24, 2026 | 24.79 |
| July 23, 2026 | 24.83 |
| July 22, 2026 | 24.43 |
| July 21, 2026 | 25.13 |
| July 20, 2026 | 24.33 |
| Date | Value |
|---|---|
| July 17, 2026 | 25.51 |
| July 16, 2026 | 24.60 |
| July 15, 2026 | 25.49 |
| July 14, 2026 | 23.85 |
| July 13, 2026 | 23.39 |
| July 10, 2026 | 23.44 |
| July 09, 2026 | 24.26 |
| July 08, 2026 | 22.44 |
| July 07, 2026 | 23.17 |
| July 06, 2026 | 23.93 |
| July 02, 2026 | 23.58 |
| July 01, 2026 | 24.90 |
| June 30, 2026 | 23.87 |
| June 29, 2026 | 15.80 |
| June 26, 2026 | 15.47 |
| June 25, 2026 | 14.95 |
| June 24, 2026 | 14.28 |
| June 23, 2026 | 12.72 |
| June 22, 2026 | 12.82 |
| June 18, 2026 | 12.94 |
| June 17, 2026 | 12.39 |
| June 16, 2026 | 12.71 |
| June 15, 2026 | 12.89 |
| June 12, 2026 | 12.99 |
| June 11, 2026 | 13.83 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Personalis, Inc. | 7.726 |
| 10X Genomics, Inc. | 10.07 |
| Alamar Biosciences, Inc. (California) | 7.261 |
| Champions Oncology, Inc. | 17.59 |
| Medpace Holdings, Inc. | 39.79 |
Price to Book Value Related Metrics
| PS Ratio | 13.09 |
| Price | 25.54 |
| Earnings Yield | -1.60% |
| Market Cap | 4.062B |